Found: 26
Select item for more details and to access through your institution.
Editorial: Therapeutics in pulmonary arterial hypertension.
- Published in:
- Frontiers in Cardiovascular Medicine, 2024, p. 1, doi. 10.3389/fcvm.2024.1463305
- By:
- Publication type:
- Article
Neuregulin‐1 attenuates right ventricular diastolic stiffness in experimental pulmonary hypertension.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2019, v. 46, n. 3, p. 255, doi. 10.1111/1440-1681.13043
- By:
- Publication type:
- Article
Update on pathophysiology and preventive strategies of anthracycline‐induced cardiotoxicity.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2019, v. 46, n. 3, p. 204, doi. 10.1111/1440-1681.13036
- By:
- Publication type:
- Article
Nicotinamide for the treatment of heart failure with preserved ejection fraction.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 580, p. 1, doi. 10.1126/scitranslmed.abd7064
- By:
- Publication type:
- Article
Therapeutic Approaches in Pulmonary Arterial Hypertension with Beneficial Effects on Right Ventricular Function—Preclinical Studies.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 21, p. 15539, doi. 10.3390/ijms242115539
- By:
- Publication type:
- Article
Vitamin D Receptor Deficiency Upregulates Pulmonary Artery Kv7 Channel Activity.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 15, p. 12350, doi. 10.3390/ijms241512350
- By:
- Publication type:
- Article
Unraveling the Impact of miR-146a in Pulmonary Arterial Hypertension Pathophysiology and Right Ventricular Function.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 15, p. 8054, doi. 10.3390/ijms25158054
- By:
- Publication type:
- Article
Corticotropin‐releasing hormone and obesity: From fetal life to adulthood.
- Published in:
- Obesity Reviews, 2024, v. 25, n. 8, p. 1, doi. 10.1111/obr.13763
- By:
- Publication type:
- Article
Heart Failure with Preserved Ejection Fraction: a Pharmacotherapeutic Update.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 4, p. 815, doi. 10.1007/s10557-021-07306-8
- By:
- Publication type:
- Article
Cardiovascular Effects of Urocortin-2: Pathophysiological Mechanisms and Therapeutic Potential.
- Published in:
- Cardiovascular Drugs & Therapy, 2019, v. 33, n. 5, p. 599, doi. 10.1007/s10557-019-06895-9
- By:
- Publication type:
- Article
Role of Ion Channel Remodeling in Endothelial Dysfunction Induced by Pulmonary Arterial Hypertension.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 4, p. 484, doi. 10.3390/biom12040484
- By:
- Publication type:
- Article
Improvement in left intraventricular pressure gradients after aortic valve replacement in aortic stenosis patients.
- Published in:
- Experimental Physiology, 2017, v. 102, n. 4, p. 411, doi. 10.1113/EP086191
- By:
- Publication type:
- Article
Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart.
- Published in:
- Journal of Physiology, 2023, v. 601, n. 17, p. 3717, doi. 10.1113/JP284936
- By:
- Publication type:
- Article
Neuregulin-1 improves right ventricular function and attenuates experimental pulmonary arterial hypertension.
- Published in:
- Cardiovascular Research, 2016, v. 109, n. 1, p. 44, doi. 10.1093/cvr/cvv244
- By:
- Publication type:
- Article
Urocortins as biomarkers in cardiovascular disease.
- Published in:
- Clinical Science, 2022, v. 136, n. 1, p. 1, doi. 10.1042/CS20210732
- By:
- Publication type:
- Article
Cardiovascular effects of relaxin-2: therapeutic potential and future perspectives.
- Published in:
- Clinical Research in Cardiology, 2024, v. 113, n. 8, p. 1137, doi. 10.1007/s00392-023-02305-1
- By:
- Publication type:
- Article
At the heart of artificial intelligence: the future might well be based on synthetic cells.
- Published in:
- Cardiovascular Research, 2022, v. 118, n. 12, p. e82, doi. 10.1093/cvr/cvac129
- By:
- Publication type:
- Article
Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload.
- Published in:
- Cardiovascular Research, 2021, v. 117, n. 12, p. 2474, doi. 10.1093/cvr/cvab016
- By:
- Publication type:
- Article
Corrigendum to: Scientist on the spot: Exploring the cause and cure for pulmonary arterial hypertension.
- Published in:
- Cardiovascular Research, 2021, v. 117, n. 9, p. 2068, doi. 10.1093/cvr/cvab191
- By:
- Publication type:
- Article
Scientist on the Spot: Exploring the cause and cure for pulmonary arterial hypertension.
- Published in:
- Cardiovascular Research, 2021, v. 117, n. 6, p. e82, doi. 10.1093/cvr/cvab091
- By:
- Publication type:
- Article
Avalanching nanoparticles bring new light to cardiovascular imaging.
- Published in:
- Cardiovascular Research, 2021, v. 117, n. 5, p. e60, doi. 10.1093/cvr/cvab092
- By:
- Publication type:
- Article
Highlights of American Heart Association Scientific Sessions 2020: a virtual experience.
- Published in:
- Cardiovascular Research, 2021, v. 117, n. 1, p. e10, doi. 10.1093/cvr/cvaa346
- By:
- Publication type:
- Article
Mobile cardiology during the COVID-19 outbreak.
- Published in:
- Cardiovascular Research, 2020, v. 116, n. 12, p. e149, doi. 10.1093/cvr/cvaa270
- By:
- Publication type:
- Article
Inside the heart of COVID-19.
- Published in:
- Cardiovascular Research, 2020, v. 116, n. 6, p. e59, doi. 10.1093/cvr/cvaa086
- By:
- Publication type:
- Article
Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension.
- Published in:
- Cardiovascular Research, 2018, v. 114, n. 8, p. 1165, doi. 10.1093/cvr/cvy076
- By:
- Publication type:
- Article
Loss of KCNK3 is a hallmark of RV hypertrophy/ dysfunction associated with pulmonary hypertension.
- Published in:
- Cardiovascular Research, 2018, v. 114, n. 6, p. 880, doi. 10.1093/cvr/cvy016
- By:
- Publication type:
- Article